The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| CONSTELLIUM NV | CL A | N22035104 | 125,905 | 16,393,903 | SH | DFND | 1 | 0 | 16,393,903 | 0 | |
| CRINETICS PHARMACEUTICALS | COM | 22663K107 | 218 | 12,418 | SH | DFND | 2 | 0 | 12,418 | 0 | |
| CRITEO S A | SPONS ADS | 226718104 | 30,967 | 2,718,752 | SH | DFND | 1 | 0 | 2,718,752 | 0 | |
| MILLENDO THERAPEUTICS INC | COM | 60040X103 | 1,898 | 1,078,670 | SH | DFND | 2 | 0 | 1,078,670 | 0 | |
| SEQUANS COMMUNICATIONS S A | SPONS ADS | 817323108 | 21,185 | 3,450,259 | SH | DFND | 1 | 0 | 12,085,561 | 0 | |
| TALEND S A | ADS | 874224207 | 55,903 | 1,612,895 | SH | DFND | 2 | 0 | 1,612,895 | 0 | |
| TECHNIPFMC PLC | COM | G87110105 | 169,362 | 24,688,691 | SH | DFND | 1 | 0 | 24,688,691 | 0 | |